Abstract
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| Original language | English |
|---|---|
| Patent number | 8012478 |
| Publication status | Published - 2010 Apr 8 |
Fingerprint
Bone Neoplasms
Anti-Idiotypic Antibodies
Stroke
Breast Neoplasms
Antibodies
interleukin 20
Cite this
Chang, M-S. (2010). Use of Anti-IL-20 antibody for treating stroke. (Patent No. 8012478).
@misc{4c6a5e3a39bf4276abe5dc37383cb323,
title = "Use of Anti-IL-20 antibody for treating stroke",
abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",
author = "Ming-Shi Chang",
year = "2010",
month = "4",
day = "8",
language = "English",
type = "Patent",
note = "8012478",
}
Chang, M-S 2010, Use of Anti-IL-20 antibody for treating stroke, Patent No. 8012478.
Use of Anti-IL-20 antibody for treating stroke. / Chang, Ming-Shi (Inventor).
Patent No.: 8012478.Research output: Patent
TY - PAT
T1 - Use of Anti-IL-20 antibody for treating stroke
AU - Chang, Ming-Shi
PY - 2010/4/8
Y1 - 2010/4/8
N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
M3 - Patent
M1 - 8012478
ER -
Chang M-S, inventor. Use of Anti-IL-20 antibody for treating stroke. 8012478. 2010 Apr 8.